The forecasted import volume of blood-grouping reagents to the Philippines shows a steady increase from 2024 to 2028. Starting at 61.91 thousand kilograms in 2024, the imports are projected to rise consistently each year, reaching 71.66 thousand kilograms by 2028. This data indicates an overall positive growth trend, with the year-on-year variations reflecting steady growth rates as well. In 2023, the imports stood at a certain volume, which serves as a baseline for these projections.
The year-on-year percentage variations for the first two forecasted years are as follows:
- 2024 to 2025: Approximately 4.06% increase
- 2025 to 2026: Approximately 3.82% increase
The Compound Annual Growth Rate (CAGR) over the five-year forecast period from 2024 to 2028 averages around 3.75% per year, signifying a moderate yet stable growth rate.
Future trends to watch for include potential technological advancements in blood-typing methodologies, changes in healthcare policy and procurement in the Philippines, and global supply chain dynamics that could impact the availability and cost of reagents.
